OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice
Yeon‐Joo Ju, Namkwon Kim, Min Sung Gee, et al.
European Journal of Pharmacology (2020) Vol. 884, pp. 173416-173416
Closed Access | Times Cited: 12
Yeon‐Joo Ju, Namkwon Kim, Min Sung Gee, et al.
European Journal of Pharmacology (2020) Vol. 884, pp. 173416-173416
Closed Access | Times Cited: 12
Showing 12 citing articles:
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
S. Sri Sabari, Kiruthika Balasubramani, Mahalaxmi Iyer, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4547-4573
Open Access | Times Cited: 31
S. Sri Sabari, Kiruthika Balasubramani, Mahalaxmi Iyer, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4547-4573
Open Access | Times Cited: 31
Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs
Golnaz Goodarzi, Sadra Samavarchi Tehrani, Saeed Ebrahimi Fana, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 6, pp. 1769-1800
Closed Access | Times Cited: 19
Golnaz Goodarzi, Sadra Samavarchi Tehrani, Saeed Ebrahimi Fana, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 6, pp. 1769-1800
Closed Access | Times Cited: 19
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17
Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson’s disease model
Xiaofei Qiu, Qinghui Wang, Liyan Hou, et al.
Toxicology Letters (2021) Vol. 349, pp. 1-11
Closed Access | Times Cited: 39
Xiaofei Qiu, Qinghui Wang, Liyan Hou, et al.
Toxicology Letters (2021) Vol. 349, pp. 1-11
Closed Access | Times Cited: 39
ATP-sensitive potassium channels: A double-edged sword in neurodegenerative diseases
Jirong Lv, Xue Xiao, Mingxia Bi, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101676-101676
Closed Access | Times Cited: 21
Jirong Lv, Xue Xiao, Mingxia Bi, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101676-101676
Closed Access | Times Cited: 21
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
Bruno Dutra Arbo, Lúcia Emanueli Schimith, Michele Goulart dos Santos, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174800-174800
Open Access | Times Cited: 20
Bruno Dutra Arbo, Lúcia Emanueli Schimith, Michele Goulart dos Santos, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174800-174800
Open Access | Times Cited: 20
Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Antidiabetic drugs in Parkinson’s disease
Yoshajandith Aguirre-Vidal, Sergio Montes, Ana Carolina Mota-López, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 11, pp. 100265-100265
Open Access | Times Cited: 3
Yoshajandith Aguirre-Vidal, Sergio Montes, Ana Carolina Mota-López, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 11, pp. 100265-100265
Open Access | Times Cited: 3
Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer’s Disease
Caitlin M. Carroll, Ruth M. Benca
Biomolecules (2024) Vol. 14, Iss. 3, pp. 274-274
Open Access | Times Cited: 2
Caitlin M. Carroll, Ruth M. Benca
Biomolecules (2024) Vol. 14, Iss. 3, pp. 274-274
Open Access | Times Cited: 2
A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in C. elegans
Amalia García-García, Sara Rojas, Lorenzo Rivas-García, et al.
Chemical Communications (2021) Vol. 58, Iss. 10, pp. 1514-1517
Open Access | Times Cited: 14
Amalia García-García, Sara Rojas, Lorenzo Rivas-García, et al.
Chemical Communications (2021) Vol. 58, Iss. 10, pp. 1514-1517
Open Access | Times Cited: 14
Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats
Yousef A. Bin Jardan, Abdul Ahad, Mohammad Raish, et al.
Saudi Pharmaceutical Journal (2021) Vol. 29, Iss. 7, pp. 719-723
Open Access | Times Cited: 6
Yousef A. Bin Jardan, Abdul Ahad, Mohammad Raish, et al.
Saudi Pharmaceutical Journal (2021) Vol. 29, Iss. 7, pp. 719-723
Open Access | Times Cited: 6
Carbon paste-glibanclamide-graphene oxide modified electrode analysis for dopamine
L.S. Manjunatha, B.E. Kumara Swamy
Chemical Data Collections (2024) Vol. 53, pp. 101157-101157
Closed Access
L.S. Manjunatha, B.E. Kumara Swamy
Chemical Data Collections (2024) Vol. 53, pp. 101157-101157
Closed Access
